Figure F-176 is titled “Rate of fatigue for topiramate compared with placebo.” The figure displays a forest plot reporting the risk difference of fatigue for topiramate compared with placebo. The forest plot depicts a higher rate of fatigue among patients treated with topiramate (1 trial, risk difference 0.20, 95% CI 0.00 to 0.40) compared with placebo.

Figure F-176Rate of fatigue for topiramate compared with placebo

Timing of outcome assessment: 12 weeks.

From: Appendix F, Meta-Analysis

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.